Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 4182 | 1756 | 33.9 | 84% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CHRONIC HEPATITIS C | Author keyword | 66 | 17% | 21% | 362 |
| 2 | INTERFERON THERAPY | Author keyword | 19 | 25% | 4% | 68 |
| 3 | HCV RNA | Author keyword | 15 | 18% | 4% | 78 |
| 4 | DAILY INTERFERON | Author keyword | 11 | 100% | 0% | 6 |
| 5 | CONSENSUS INTERFERON | Author keyword | 10 | 40% | 1% | 19 |
| 6 | BRANCHED DNA PROBE ASSAY | Author keyword | 9 | 83% | 0% | 5 |
| 7 | INTERFERON RETREATMENT | Author keyword | 6 | 71% | 0% | 5 |
| 8 | SERUM HCV RNA LEVEL | Author keyword | 6 | 100% | 0% | 4 |
| 9 | SUSTAINED RESPONDERS | Author keyword | 6 | 100% | 0% | 4 |
| 10 | HEPATITIS C VIRUS RNA | Author keyword | 5 | 20% | 1% | 23 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CHRONIC HEPATITIS C | 66 | 17% | 21% | 362 | Search CHRONIC+HEPATITIS+C | Search CHRONIC+HEPATITIS+C |
| 2 | INTERFERON THERAPY | 19 | 25% | 4% | 68 | Search INTERFERON+THERAPY | Search INTERFERON+THERAPY |
| 3 | HCV RNA | 15 | 18% | 4% | 78 | Search HCV+RNA | Search HCV+RNA |
| 4 | DAILY INTERFERON | 11 | 100% | 0% | 6 | Search DAILY+INTERFERON | Search DAILY+INTERFERON |
| 5 | CONSENSUS INTERFERON | 10 | 40% | 1% | 19 | Search CONSENSUS+INTERFERON | Search CONSENSUS+INTERFERON |
| 6 | BRANCHED DNA PROBE ASSAY | 9 | 83% | 0% | 5 | Search BRANCHED+DNA+PROBE+ASSAY | Search BRANCHED+DNA+PROBE+ASSAY |
| 7 | INTERFERON RETREATMENT | 6 | 71% | 0% | 5 | Search INTERFERON+RETREATMENT | Search INTERFERON+RETREATMENT |
| 8 | SERUM HCV RNA LEVEL | 6 | 100% | 0% | 4 | Search SERUM+HCV+RNA+LEVEL | Search SERUM+HCV+RNA+LEVEL |
| 9 | SUSTAINED RESPONDERS | 6 | 100% | 0% | 4 | Search SUSTAINED+RESPONDERS | Search SUSTAINED+RESPONDERS |
| 10 | HEPATITIS C VIRUS RNA | 5 | 20% | 1% | 23 | Search HEPATITIS+C+VIRUS+RNA | Search HEPATITIS+C+VIRUS+RNA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHRONIC NON A | 214 | 53% | 16% | 282 |
| 2 | ALFA | 136 | 41% | 15% | 258 |
| 3 | ALFA THERAPY | 70 | 44% | 7% | 120 |
| 4 | VIRUS RNA | 64 | 28% | 11% | 199 |
| 5 | NON B HEPATITIS | 53 | 11% | 25% | 442 |
| 6 | HUMAN ALPHA INTERFERON | 22 | 33% | 3% | 56 |
| 7 | TRIPLE ANTIVIRAL THERAPY | 21 | 90% | 1% | 9 |
| 8 | NORMAL ALT LEVELS | 19 | 63% | 1% | 19 |
| 9 | ALPHA THERAPY | 19 | 18% | 5% | 95 |
| 10 | RECOMBINANT INTERFERON ALFA | 13 | 25% | 3% | 46 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The treatment of chronic viral hepatitis | 1997 | 767 | 86 | 41% |
| Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon - A meta-analysis of randomized trials | 2001 | 103 | 34 | 71% |
| Should we treat HCV carriers with normal ALT levels? The 5Ws' dilemma | 2012 | 10 | 55 | 69% |
| Evaluation of amantadine in chronic hepatitis C: a meta-analysis | 2004 | 56 | 62 | 77% |
| Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels | 2005 | 38 | 52 | 63% |
| Pathogenesis, diagnosis and management of hepatitis C | 2000 | 125 | 107 | 37% |
| Review article: management of patients with chronic hepatitis C virus infection and 'normal' alanine aminotransferase activity | 2006 | 26 | 101 | 62% |
| Past, present, and future hepatitis C treatments | 2004 | 48 | 45 | 58% |
| Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C | 2013 | 5 | 157 | 50% |
| Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy | 2015 | 2 | 39 | 46% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SPEDALI RIUNITI SANTA CHIARA | 4 | 75% | 0.2% | 3 |
| 2 | RECH CLAUDE BERNARD HEPATITES VIRALES | 3 | 27% | 0.5% | 9 |
| 3 | HEPAT UNIT | 3 | 25% | 0.5% | 9 |
| 4 | MED GEN GASTROENTEROL | 2 | 67% | 0.1% | 2 |
| 5 | INTERNAL MED F MAGRASSI | 2 | 36% | 0.2% | 4 |
| 6 | SECT LIVER DIS LIVER TRANSPLANTAT | 2 | 43% | 0.2% | 3 |
| 7 | IST METODOL DIAGNOST AVANZATE | 1 | 25% | 0.3% | 5 |
| 8 | C PI MED | 1 | 100% | 0.1% | 2 |
| 9 | MED C PI | 1 | 50% | 0.1% | 2 |
| 10 | MED CLIN 2A | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000212381 | HCV GENOTYPES//INTERFERON SENSITIVITY DETERMINING REGION//HYPERVARIABLE REGION 1 |
| 2 | 0.0000208111 | TELAPREVIR//RIBAVIRIN//BOCEPREVIR |
| 3 | 0.0000188398 | RIBA//ANTI HCV//NON A NON B HEPATITIS |
| 4 | 0.0000154430 | HCV CORE ANTIGEN//HCV CORE ANTIGEN ASSAY//HCV RNA STABILITY |
| 5 | 0.0000136871 | OCCULT HCV//OCCULT HEPATITIS C//OCCULT HCV INFECTION |
| 6 | 0.0000110116 | ACUTE HEPATITIS C//INTRAFAMILIAL TRANSMISSION//MOTHER TO INFANT TRANSMISSION |
| 7 | 0.0000080763 | INTEGRATED PROGRAM IMMUNOL//DENDRIT CELL BIOL CLIN PLICAT//LIVER DIS SECT |
| 8 | 0.0000078256 | INTERFERON ASSOCIATED RETINOPATHY//HUNTER MAIL REG//CHRONIC ACTIVE HEPATITIS C |
| 9 | 0.0000072153 | STEATOSIS//HEPATOGENOUS DIABETES//DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI |
| 10 | 0.0000070109 | IGM ANTI HBC//ANTI HBC IGM//HBVDNA |